UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist

The Journal of pharmacology and experimental therapeutics, 2002-03, Vol.300 (3), p.1122

2002

Volltextzugriff (PDF)

Electrophysiologic Characterization of Dronedarone in Guinea Pig Ventricular Cells

Journal of cardiovascular pharmacology, 2003-02, Vol.41 (2), p.191-202

2003

Volltextzugriff (PDF)

Involvement of nitric oxide in amiodarone- and dronedarone-induced coronary vasodilation in guinea pig heart

European journal of pharmacology, 2004-08, Vol.496 (1), p.119-127

2004

Volltextzugriff (PDF)

Inhibitory Effects of Dronedarone on Muscarinic K+ Current in Guinea Pig Atrial Cells

Journal of cardiovascular pharmacology, 2000-12, Vol.36 (6), p.802-805

2000

Volltextzugriff (PDF)

Angiotensin AT1 Receptor Antagonist Irbesartan Decreases Lesion Size, Chemokine Expression, and Macrophage Accumulation in Apolipoprotein E-Deficient Mice

Journal of cardiovascular pharmacology, 2001-09, Vol.38 (3), p.395-405

2001

Volltextzugriff (PDF)

Cellular and in vivo electrophysiological effects of dronedarone in normal and postmyocardial infarcted rats

The Journal of pharmacology and experimental therapeutics, 2000-01, Vol.292 (1), p.415

2000

Volltextzugriff (PDF)

Selective vasopressin, angiotensin II, or dual receptor blockade with developing congestive heart failure

The Journal of pharmacology and experimental therapeutics, 2000-06, Vol.293 (3), p.852

2000

Volltextzugriff (PDF)

Evaluation of the ability of irbesartan to cross the blood–brain barrier following acute intragastric treatment

European journal of pharmacology, 1998-07, Vol.352 (1), p.15-21

1998

Volltextzugriff (PDF)

Effects of Angiotensin II AT1-Receptor Blockade on Coronary Dynamics, Function, and Structure in Postischemic Heart Failure in Rats

Journal of cardiovascular pharmacology, 2000-09, Vol.36 (3), p.329-337

2000

Volltextzugriff (PDF)

A novel class of calcium-entry blockers: the 1-[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines

Journal of medicinal chemistry, 1992-03, Vol.35 (6), p.981-988

1992

Volltextzugriff (PDF)

Effects of irbesartan (SR 47436/BMS-186295) on angiotensin II-induced pressor responses in the pithed rat: potential mechanisms of action

European journal of pharmacology, 1995-08, Vol.281 (2), p.161-171

1995

Volltextzugriff (PDF)

Effect of SR 47436, a novel angiotensin II AT1 receptor antagonist, on human vascular smooth muscle cells in vitro

European journal of pharmacology, 1994-01, Vol.251 (2-3), p.143-150

1994

Volltextzugriff (PDF)

Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models

European journal of pharmacology, 1994-11, Vol.264 (3), p.307-316

1994

Volltextzugriff (PDF)

Early and late haemodynamic and morphological effects of angiotensin II subtype 1 receptor blockade during genetic hypertension development

Journal of hypertension, 1995-06, Vol.13 (6), p.675-682

1995

Volltextzugriff (PDF)

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist

The Journal of clinical investigation, 1996-12, Vol.98 (12), p.2729-2738

1996

Volltextzugriff (PDF)

Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone

British journal of pharmacology, 2001-07, Vol.133 (5), p.625-634

2001

Volltextzugriff (PDF)

In Vivo and In Vitro Antiarrhythmic Effects of SSR149744C in Animal Models of Atrial Fibrillation and Ventricular Arrhythmias

Journal of cardiovascular pharmacology, 2005-02, Vol.45 (2), p.125-135

2005

Volltextzugriff (PDF)

Oral administration of peptides: Study of a glycerolipidic prodrug

International journal of pharmaceutics, 1995-02, Vol.115 (1), p.45-52

1995

Volltextzugriff (PDF)

Pharmacological study of SR 47436, a non-peptide angiotensin II AT1-receptor antagonist, in conscious monkeys

Journal of hypertension, 1993-11, Vol.11 (11), p.1187-1194

1993

Volltextzugriff (PDF)

In Vivo and In Vitro Characterization of the Novel Antiarrhythmic Agent SSR149744C: Electrophysiological, Anti-Adrenergic, and Anti-Angiotensin II Effects

Journal of cardiovascular pharmacology, 2004-08, Vol.44 (2), p.244-257

2004

Volltextzugriff (PDF)

Effects of dronedarone and amiodarone on plasma thyroid hormones and on the basal and postischemic performance of the isolated rat heart

European journal of pharmacology, 2002-05, Vol.444 (3), p.191-196

2002

Volltextzugriff (PDF)

Effects of long-term angiotensin II AT1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in rats

Cardiovascular research, 1999, Vol.41 (1), p.100-108

1999

Volltextzugriff (PDF)

Hemodynamic and Antiadrenergic Effects of Dronedarone and Amiodarone in Animals with a Healed Myocardial Infarction

Journal of cardiovascular pharmacology, 2000-09, Vol.36 (3), p.376-383

2000

Volltextzugriff (PDF)

Aldehydic peptides inhibiting renin

FEBS letters, 1984-02, Vol.167 (2), p.273-276

1984

Volltextzugriff (PDF)

Study of SR 142801, a new potent non‐peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea‐pig

British journal of pharmacology, 1996-07, Vol.118 (5), p.1095-1102

1996

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(64)

Sprache

Englisch
(63)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist

Electrophysiologic Characterization of Dronedarone in Guinea Pig Ventricular Cells

Involvement of nitric oxide in amiodarone- and dronedarone-induced coronary vasodilation in guinea pig heart

Inhibitory Effects of Dronedarone on Muscarinic K+ Current in Guinea Pig Atrial Cells

Angiotensin AT1 Receptor Antagonist Irbesartan Decreases Lesion Size, Chemokine Expression, and Macrophage Accumulation in Apolipoprotein E-Deficient Mice

Cellular and in vivo electrophysiological effects of dronedarone in normal and postmyocardial infarcted rats

Selective vasopressin, angiotensin II, or dual receptor blockade with developing congestive heart failure

Evaluation of the ability of irbesartan to cross the blood–brain barrier following acute intragastric treatment

Effects of Angiotensin II AT1-Receptor Blockade on Coronary Dynamics, Function, and Structure in Postischemic Heart Failure in Rats

A novel class of calcium-entry blockers: the 1-[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines

Effects of irbesartan (SR 47436/BMS-186295) on angiotensin II-induced pressor responses in the pithed rat: potential mechanisms of action

Effect of SR 47436, a novel angiotensin II AT1 receptor antagonist, on human vascular smooth muscle cells in vitro

Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models

Early and late haemodynamic and morphological effects of angiotensin II subtype 1 receptor blockade during genetic hypertension development

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist

Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone

In Vivo and In Vitro Antiarrhythmic Effects of SSR149744C in Animal Models of Atrial Fibrillation and Ventricular Arrhythmias

Oral administration of peptides: Study of a glycerolipidic prodrug

Pharmacological study of SR 47436, a non-peptide angiotensin II AT1-receptor antagonist, in conscious monkeys

In Vivo and In Vitro Characterization of the Novel Antiarrhythmic Agent SSR149744C: Electrophysiological, Anti-Adrenergic, and Anti-Angiotensin II Effects

Effects of dronedarone and amiodarone on plasma thyroid hormones and on the basal and postischemic performance of the isolated rat heart

Effects of long-term angiotensin II AT1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in rats

Hemodynamic and Antiadrenergic Effects of Dronedarone and Amiodarone in Animals with a Healed Myocardial Infarction

Aldehydic peptides inhibiting renin

Study of SR 142801, a new potent non‐peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea‐pig

Suchergebnisse filtern